On August 25, 2022, the third phase of the Fudan Zhongshan Patent Salon proceeded as planned at Zhongshan Hospital affiliated to Fudan University. Ms. Chen Xiumin, Chairman and General Manager of ConFlow MedTech, one of the key contracting parties for this patent project transformation, participated in the signing ceremony.
During the signing ceremony, Zhang Quan, Director of the Shanghai Municipal Commission of Science and Technology, highlighted, "This event advances the high-quality advancement of scientific and technological innovation at Zhongshan Hospital, expedites the establishment of a demonstrative hub for medical-industrial integration in Shanghai, and bolsters Zhongshan Hospital's role as Shanghai's representative in the global competition and collaboration within medical science and technology innovation".
Zhongshan Hospital, through its annual Fudan Zhongshan Patent Salon, has established a conduit for communication and collaboration between healthcare innovators and exceptional innovative enterprises, fostering a culture of innovation within its walls. Wang Xin, Secretary of Zhongshan Hospital, introduced this initiative, highlighting the significance of a series of patent transfers that represent a pivotal milestone in the third Fudan Zhongshan Patent Salon. Secretary Wang Xin emphasized the genuine cooperation between renowned healthcare institutions in Shanghai and outstanding local enterprises. This collaboration aims to construct a robust platform for integrating innovation and transformation, facilitating meaningful and sound partnerships between medical professionals and businesses, with a particular focus on Shanghai's biomedical industry landscape. This collaborative effort mobilizes and leverages the abundant resources and expertise of both parties to advance research and development in medical technologies and clinical applications. The ultimate goal is to bolster China's prowess in the field of medicine, contributing not only to the nation's healthcare sector but also to global medical advancements.
At this cherished gathering, Zhou Jian, Vice President of Zhongshan Hospital, highlighted and outlined the hospital's initiatives in scientific innovation and transformation. He stated, "In recent years, Zhongshan Hospital has prioritized innovative collaborations with enterprises in the healthcare sector. We have actively and passionately facilitated the translation of clinical research into tangible advancements in science and technology. For numerous consecutive years, we have consistently ranked as the top hospital in Shanghai for scientific research and production. Notably, we have achieved significant milestones in the fields of medical devices, diagnostic kits, drug R&D, and the conversion of research into solutions for major diseases.
Chen Xiumin, Chairman and General Manager of ConFlow MedTech, stated, "ConFlow MedTech, in collaboration with Zhongshan Hospital, has successfully translated six patents encompassing atrial septal shunt, reusable left ventricular isolation devices, etc. In the coming years, ConFlow MedTech will further strengthen its partnership with Zhongshan Hospital, steadfastly champion the principles of scientific and technological innovation, actively advance research and development in medical technology, facilitate clinical translation, and ultimately enhance the well-being of a broader population afflicted with cardiovascular conditions.